Omnicell (OMCL) Shares Outstanding (Diluted Average) (2010 - 2026)
Omnicell (OMCL) reported Shares Outstanding (Diluted Average) of $45.9 million for Q1 2026, down 1.4% year-over-year from $46.6 million in Q1 2025, and down 0.9% quarter-over-quarter from $46.4 million in Q4 2025.
Omnicell (OMCL) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has 17 years of Shares Outstanding (Diluted Average) data on file, last reported at $45.9 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $45.9 million, down 1.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.9 million (down 1.4% YoY), and the FY2025 annual result was $46.4 million, changed 0.23% from the prior year.
- Shares Outstanding (Diluted Average) slipped to $45.9 million in Q1 2026 per OMCL's latest filing, from $46.4 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $47.9 million in Q1 2022 and troughed at $44.9 million in Q1 2023.
- A 5-year average of $46.2 million and a median of $46.3 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) increased 3.35% in 2022, then slipped 6.33% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $45.9 million in 2022, then dropped by 1.48% to $45.2 million in 2023, then grew by 2.31% to $46.3 million in 2024, then rose by 0.23% to $46.4 million in 2025, then dropped by 0.9% to $45.9 million in 2026.
- Business Quant data shows OMCL's Shares Outstanding (Diluted Average) at $45.9 million in Q1 2026, $46.4 million in Q4 2025, and $46.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 165.99 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 221.32 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 85.01 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 82.39 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 128.29 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 199.05 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 195.16 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 130.88 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 45.94 Mn |
| 10 | Teladoc Health | 1.45 Bn | 696.57 Mn | 562.57 Mn | 179.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.94 Mn |
| Dec 31, 2025 | 46.36 Mn |
| Sep 30, 2025 | 46.66 Mn |
| Jun 30, 2025 | 46.69 Mn |
| Mar 31, 2025 | 46.60 Mn |
| Dec 31, 2024 | 46.26 Mn |
| Sep 30, 2024 | 46.43 Mn |
| Jun 30, 2024 | 46.04 Mn |
| Mar 31, 2024 | 45.73 Mn |
| Dec 31, 2023 | 45.21 Mn |
| Sep 30, 2023 | 45.60 Mn |
| Jun 30, 2023 | 45.47 Mn |
| Mar 31, 2023 | 44.89 Mn |
| Dec 31, 2022 | 45.89 Mn |
| Sep 30, 2022 | 46.76 Mn |
| Jun 30, 2022 | 46.26 Mn |
| Mar 31, 2022 | 47.92 Mn |
| Dec 31, 2021 | 47.94 Mn |
| Sep 30, 2021 | 48.34 Mn |
| Jun 30, 2021 | 47.11 Mn |